1. Home
  2. Stock quotes
  3. Stock ChromaDex Corporation
ChromaDex Corporation logo

ChromaDex Corporation CDXC

Annual report 2025
added 03-04-2026

report update icon

Country

 usaUSA

IPO year

 -

Industry

 Biotechnology

Stock Exchange

 NASDAQ CAPITAL

Shares

 79.2 M

Market Cap[1]

 $ 598 M

EBITDA (LTM)

 $ 220 K

P/E (LTM)

 -

P/S (LTM)

 4.93

EPS (LTM)

 0.2

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
MorphoSys AG MorphoSys AG
MOR
 		- 2.43 % $ 254 M Nasdaq Global Select Market germanyGermany
Advaxis Advaxis
ADXS
 		- -9.65 % $ 45.9 M Nasdaq Capital Market usaUSA
Akouos Akouos
AKUS
 		- 0.23 % $ 488 M Nasdaq Global Select Market usaUSA
Allakos Allakos
ALLK
 		- - $ 28.6 M Nasdaq Global Select Market,SPB usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
I-Mab I-Mab
IMAB
 		- - $ 866 M Nasdaq Global Select Market chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
 		- - $ 1.01 B Nasdaq Global Market usaUSA
Ampio Pharmaceuticals Ampio Pharmaceuticals
AMPE
 		- -11.43 % $ 502 K NYSE American usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
 		- -18.52 % $ 27.3 M Nasdaq Global Select Market britainBritain
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
 		- - $ 40.3 B Nasdaq Global Select Market usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
 		- - $ 10.1 M Nasdaq Global Select Market,SPB usaUSA
Applied Therapeutics Applied Therapeutics
APLT
 		- - $ 8.42 M Nasdaq Global Market,SPB usaUSA
Aptorum Group Limited Aptorum Group Limited
APM
 		$ 0.88 -1.73 % $ 6.47 M Nasdaq Global Select Market chinaChina
Biophytis SA Biophytis SA
BPTS
 		- -13.47 % $ 169 M Nasdaq Capital Market franceFrance
Genfit SA Genfit SA
GNFT
 		- 2.54 % $ 160 B Nasdaq Global Select Market franceFrance
ACADIA Pharmaceuticals ACADIA Pharmaceuticals
ACAD
 		$ 22.48 0.81 % $ 3.73 B Nasdaq Global Select Market,SPB usaUSA
Aptinyx Aptinyx
APTX
 		- -39.0 % $ 4.57 M Nasdaq Global Select Market usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
 		- -1.52 % $ 24.7 M Nasdaq Capital Market usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
 		- - $ 7.46 M Nasdaq Global Market israelIsrael
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
 		- -4.8 % $ 255 M Nasdaq Global Select Market usaUSA
AIkido Pharma AIkido Pharma
AIKI
 		- 1.93 % $ 17.4 M Nasdaq Capital Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
 		- - $ 35.4 M Nasdaq Capital Market usaUSA
Институт стволовых клеток человека Институт стволовых клеток человека
ISKJ
 		- - - MOEX russiaRussia
Aeterna Zentaris Aeterna Zentaris
AEZS
 		- 5.93 % $ 314 M Nasdaq Capital Market canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
 		- -10.17 % $ 12.2 K NYSE American usaUSA
Aravive Aravive
ARAV
 		- -13.39 % $ 1.45 M Nasdaq Global Select Market usaUSA
Aridis Pharmaceuticals Aridis Pharmaceuticals
ARDS
 		- 17.91 % $ 11.1 M Nasdaq Capital Market usaUSA
BioNTech SE BioNTech SE
BNTX
 		$ 101.39 -0.66 % $ 27.2 B Nasdaq Global Select Market germanyGermany
Checkpoint Therapeutics Checkpoint Therapeutics
CKPT
 		- - $ 169 M Nasdaq Capital Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
 		- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
 		- - $ 26.5 M Nasdaq Global Select Market usaUSA
Aquestive Therapeutics Aquestive Therapeutics
AQST
 		$ 4.06 -0.98 % $ 434 M Nasdaq Global Market usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
 		$ 23.08 -1.45 % $ 2.94 B Nasdaq Global Select Market,SPB usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
 		$ 1.49 4.58 % $ 397 M Nasdaq Global Select Market britainBritain
Aptose Biosciences Aptose Biosciences
APTO
 		- -45.71 % $ 1.2 M Nasdaq Capital Market canadaCanada
AstraZeneca PLC AstraZeneca PLC
AZN
 		- - $ 96.9 B Nasdaq Global Select Market britainBritain
AVROBIO AVROBIO
AVRO
 		- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
 		$ 2.92 -0.14 % $ 4.81 M NYSE American israelIsrael
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
Akero Therapeutics Akero Therapeutics
AKRO
 		- - $ 3.67 B Nasdaq Global Select Market,SPB usaUSA
bluebird bio bluebird bio
BLUE
 		- - $ 546 M Nasdaq Global Select Market,SPB usaUSA
CureVac N.V. CureVac N.V.
CVAC
 		- - $ 867 M Nasdaq Global Market germanyGermany
ContraFect Corporation ContraFect Corporation
CFRX
 		- -5.16 % $ 5.39 M Nasdaq Capital Market usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
 		$ 1.7 -1.45 % $ 114 M Nasdaq Capital Market usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
 		- - $ 1.2 B Nasdaq Capital Market usaUSA
BioXcel Therapeutics BioXcel Therapeutics
BTAI
 		$ 1.06 -3.21 % $ 12.9 M Nasdaq Global Select Market,SPB usaUSA
Cabaletta Bio Cabaletta Bio
CABA
 		$ 2.83 -2.92 % $ 284 M Nasdaq Global Select Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.